Order Article Reprints

Esteban-Vazquez A, Steiner M, Castañeda E, Andreu-Vazquez C, Thiussard IJ, Somodevilla A, Gracia-Martínez M, Sánchez-Diaz R, García-Yubero C, Paredes-Romero MB, et al. The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors. Vaccines. 2023; 11(10):1610. https://doi.org/10.3390/vaccines11101610

Esteban-Vazquez, Ana, Martina Steiner, Elisabet Castañeda, Cristina Andreu-Vazquez, Israel J. Thiussard, Angela Somodevilla, Moisés Gracia-Martínez, Rosa Sánchez-Diaz, Cristina García-Yubero, Maria Beatriz Paredes-Romero, and et al. 2023. "The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors" Vaccines 11, no. 10: 1610. https://doi.org/10.3390/vaccines11101610

Esteban-Vazquez, A., Steiner, M., Castañeda, E., Andreu-Vazquez, C., Thiussard, I. J., Somodevilla, A., Gracia-Martínez, M., Sánchez-Diaz, R., García-Yubero, C., Paredes-Romero, M. B., & Munoz-Fernández, S. (2023). The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors. Vaccines, 11(10), 1610. https://doi.org/10.3390/vaccines11101610